Physical Medicine & Rehabilitation · Kalkaska, MI
NPI
1699901611
Since 2009
Specialty
Physical Medicine & Rehabilitation
Code 208100000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
419 S Coral St
Kalkaska, MI, 49646
Phone (231) 285-7777
Groups this clinician bills Medicare through
Medicare paid, 2024
$114K
20,215 services
Medicare patients, 2024
42
Average age 63
Drug cost, 2024
$119K
1,623 prescriptions
Company payments, 2025
$965
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew S Cole was code J0585 (injection, onabotulinumtoxina, 1 unit), 19,500 times for 26 patients. In total Andrew S Cole billed 20,215 services in 28 codes, and Medicare paid $114K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 19,500 | 26 | $4.78 | $93K |
| 99214 Office E&M - Established | Office | 46 | 27 | $81.90 | $3,768 |
| 64615 Musculoskeletal | Office | 26 | 12 | $108.53 | $2,822 |
| 95874 Musculoskeletal | Office | 24 | 13 | $59.61 | $1,431 |
| 99213 Office E&M - Established | Office | 19 | 14 | $70.11 | $1,332 |
| 95886 Electrical Nerve Conductivity | Office | 12 | 11 | $76.21 | $914 |
By year: 2022 $112K for 18,442 services; 2023 $114K for 18,126 services; 2024 $114K for 20,215 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew S Cole prescribed most often to Medicare patients was Desvenlafaxine Succinate Er (Desvenlafaxine Succinate), with 103 prescriptions and refills. In total Andrew S Cole wrote 1,623 Medicare prescriptions that cost $119K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 103 | 218 | 31 | $7,150 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 92 | 92 | 13 | $2,903 |
| Tizanidine Hcl Generic | 90 | 114 | 32 | $1,329 |
| Baclofen Generic | 88 | 137 | 25 | $1,510 |
| Gabapentin Generic | 79 | 127 | 21 | $1,792 |
| Tramadol Hcl Generic | 61 | 61 | 11 | $687 |
| Pregabalin Generic | 61 | 73 | Under 11 | $2,739 |
| Morphine Sulfate Er Morphine Sulfate | 59 | 59 | Under 11 | $1,948 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 50 | 84 | 19 | $1,022 |
| Diazepam Generic | 36 | 36 | 14 | $159 |
| Oxycodone Hcl Generic | 32 | 32 | Under 11 | $857 |
| Dantrolene Sodium Generic | 31 | 38 | Under 11 | $5,735 |
| Meloxicam Generic | 28 | 40 | Under 11 | $173 |
| Sumatriptan Succinate Generic | 24 | 35 | 13 | $787 |
| Glycopyrrolate Generic | 24 | 28 | Under 11 | $959 |
Brand drugs: 127 claims; generic drugs: 1,496 claims; opioid claims: 300.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew S Cole $965 ($965 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $515.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 23 | $515 |
| Medtronic, Inc. MDT | 1 | $142 |
| Braeburn Inc. | 1 | $120 |
| Pfizer Inc. PFE | 3 | $48.89 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $29.05 |
| Boston Scientific Corporation BSX | 1 | $24.27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $23.42 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $23 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $22.41 |
| Merz Pharmaceuticals, LLC | 1 | $16.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.